Cosmax Nbt, Inc. (KOSDAQ:222040)
South Korea · Delayed Price · Currency is KRW 8,170.00
+240.00 (3.03%)
At close: Jul 10, 2026
Cosmax Nbt Market Cap
Cosmax Nbt has a market cap or net worth of 167.93 billion as of July 10, 2026. Its market cap has increased by 57.72% in one year.
Market Cap
167.93B
Enterprise Value
280.36B
Revenue
308.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,170.00
Market Cap Chart
Since December 16, 2015, Cosmax Nbt's market cap has decreased from 299.11B to 167.93B, a decrease of -43.86%. That is a compound annual growth rate of -5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 167.93B | 133.43% |
| Dec 30, 2025 | 71.94B | 13.45% |
| Dec 30, 2024 | 63.41B | -51.95% |
| Dec 28, 2023 | 131.96B | 49.12% |
| Dec 29, 2022 | 88.49B | -25.78% |
| Dec 30, 2021 | 119.23B | -32.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 237.91B |
| CellBion | 192.80B |
| Vivozon Pharmaceutical | 157.33B |
| DAE HWA Pharmaceutical | 156.42B |
| GC WellBeing | 146.34B |
| Kyung Dong Pharmaceutical | 134.57B |
| PHARMARESEARCH BIO | 131.69B |
| High Tech Pharm | 127.39B |